http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105944142-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3691 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3604 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 |
| filingDate | 2016-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105944142-B |
| titleOfInvention | A kind of preparation method of de- cell tendon or tough belt supporting frame |
| abstract | The present invention relates to the preparation methods of a kind of de- cell tendon or tough belt supporting frame.It is designed to provide a kind of de- cell tendon or ligament collagenous fiber material having good biomechanics characteristic and biocompatibility.The animal tendon or ligament of removal outer membrane and synovial tissue are obtained, whole process in cell processes is taken off and uses the hybrid protection liquid containing ligament or tendon scaffold structural defence agent；Using the cell in high static pressure technology pre-separation ligament or tendon tissue；Residual cells core is digested using composite nucleic acid enzyme method；Loose crushing cell sheet is removed using detergent；It is rinsed using hybrid protection liquid.The present invention passes through efficient physics; the de- method of a small amount of enzyme and detergent fully removes the cell component in ligament or tendon; and the whole process protection of application protection liquid; on the basis of ensureing that nucleus purifies, the three-dimensional structure and arrangement polarity of its normal collagenous fibres are remained while the immunogenicity of reduction tendon or ligament tissue to the maximum extent. |
| priorityDate | 2016-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.